Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 8 , Pages 729-735 , August 2010

The New Genetics in Child Psychiatry

  • James J. Hudziak, M.D.

      Affiliations

    • University of Vermont, College of Medicine, Burlington, Vermont; Vrije Universiteit, Amsterdam; and ErasmusMC, Rotterdam, the Netherlands
    • Corresponding Author InformationCorrespondence to Dr. James J. Hudziak, The Vermont Center for Children, Youth and Families, University of Vermont College of Medicine, University Health Center campus, 1 South Prospect Street, Burlington, VT 05401
    • ,
  • Stephen V. Faraone, Ph.D.

      Affiliations

    • State University of New York Upstate Medical University

,Accepted 21 June 2010.

References 

  1. Human Genome Project Information. http://www.ornl.gov/sci/techresources/Human_Genome/home.shtmlAccessed April 4, 2010
  2. Nutritional and Metabolic Diseases (Genes and Disease). http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gnd&part=A86Accessed June 1, 2010
  3. International HapMap Project. http://hapmap.ncbi.nlm.nih.gov/Accessed May 12, 2010
  4. Wood AC, Neale MC. Twin studies and their implications for molecular genetic studies: Endophenotypes integrate quantitative and molecular genetics in ADHD research. J Am Acad Child Adolesc Psychiatry. 2010;49:In press
  5. Franić S, Middeldorp CM, Dolan CV, et al. Childhood and adolescent anxiety and depression: Beyond heritability. J Am Acad Child Adolesc Psychiatry. 2010;49:820–829
  6. Albaugh MD, Harder VS, Althoff RR, et al. Maternal Involvement Moderates COMT Polymorphism and Child Psychopathology Relationship. J Am Acad Child Adolesc Psychiatry. 2010;49:841–849
  7. Nigg J, Nikolas M, Burt SA. Measured gene by environment interaction in relation to attention-deficit/hyperactivity disorder (ADHD) [published online ahead of print May 6, 2010]. J Am Acad Child Adolesc Psychiatry. DOI: 10.1016/j.jaac.2010.01.025.
  8. Sudgen K, Arseneault L, Harrington HL, et al. The serotonin transporter gene moderates the development of emotional problems among children following bullying victimization. J Am Acad Child Adolesc Psychiatry. 2010;49:830–840
  9. Faraone , et al. Case control genome-wide association of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49:In press
  10. Mick E, Todorov A, Smalley S, et al. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder [published online ahead of print May 17, 2010]. J Am Acad Child Adolesc Psychiatry. DOI: 10.1016/j.jaac.2010.02.014.
  11. Faraone , et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49:In press
  12. Grados MA. The genetics of obsessive-compulsive disorder and Tourette syndrome: A molecular epidemiology review. J Am Acad Child Adolesc Psychiatry. 2010;49:810–819
  13. Haworth CMA, Plomin R. Quantitative genetics in the era of molecular genetics: Learning abilities and disabilities as an example. J Am Acad Child Adolesc Psychiatry. 2010;49:783–793
  14. Hoffman EJ, State MW. Progress in cytogenetics: Implications for child psychopathology. J Am Acad Child Adolesc Psychiatry. 2010;49:736–751
  15. Bagot RC, Meaney MJ. Epigenetics and the biological basis of gene × environment Interactions. J Am Acad Child Adolesc Psychiatry. 2010;49:752–771
  16. Grafodatskaya D, Chung B, Szatmari P, et al. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry. 2010;49:794–809
  17. Pine DS, Ernst M, Leibenluft E. Imaging genetics applications in child psychiatry. J Am Acad Child Adolesc Psychiatry. 2010;49:772–782

 Disclosure: Dr. Faraone, in the past year, has received consulting fees from and served on the advisory board for Eli Lilly and Co., Ortho-McNeil, and Shire Development. He has received research support from Eli Lilly and Co., Pfizer, Shire, and the National Institutes of Health. In previous years, Dr. Faraone has received consulting fees from, has served on the advisory boards for, or served on the speakers' bureau for Shire, McNeil, Janssen, Novartis, Pfizer, and the National Institutes of Health. Dr. Hudziak reports no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00495-8

doi: 10.1016/j.jaac.2010.06.010

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 8 , Pages 729-735 , August 2010

Article Tools